Acute Liver Injury in Patients With Pneumonia
Launched by ASSIUT UNIVERSITY · Oct 25, 2023
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the effects of pneumonia on patients who also experience acute liver injury. Acute liver injury means that the liver is not working properly, which can lead to more serious conditions like acute liver failure. The study aims to understand how pneumonia, particularly cases related to COVID-19, affects liver health in patients who have developed liver issues.
To be eligible for this trial, participants need to be 18 years or older and have pneumonia that has led to acute liver injury. However, people with certain conditions like cancer, those with weakened immune systems, or pregnant individuals cannot join the study. As the trial is not yet recruiting, patients can expect more information soon about what participating will involve. This may include medical evaluations and monitoring to help researchers learn more about the connection between pneumonia and liver health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with pneumonia that developed Acute Liver Injury
- • 2. Covid 19 pneumonia
- • 3. Patients With acute liver injury only.
- Exclusion Criteria:
- • 1. Cancer
- • 2. Immunocompromised patients i.e HIV patients and patients who take immunosuppressive medications.
- • 3. Patients who younger than 18 yrs old
- • 4. pregnancy
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assuit, , Egypt
Patients applied
Trial Officials
Zain Elabdeen Ahmed, Professor
Study Chair
Assuit Faculty of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported